De novo versus acute-on-chronic heart failure-related cardiogenic shock (CS): Differences in patient profile, therapeutic management, and prognosis. Insights from the FRENSHOCK registry | NobleID
v1
De novo versus acute-on-chronic heart failure-related cardiogenic shock (CS): Differences in patient profile, therapeutic management, and prognosis. Insights from the FRENSHOCK registry
